Pacific Biosciences of California, Inc.
PACB· Nasdaq
Released Mar 12, 2015, after the close
10-K filed Mar 12, 2015, 71 days after period end · 0001299130-15-000034
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2014 | Q4 2013 | Q4 2012 | Q4 2011dderived from reported figures |
|---|---|---|---|---|
| Revenue | $16.90M | $9.13M | $5.88M | $12.44M |
| Net Income | -$18.98M | -$17.23M | -$21.67M | -$22.82M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pacific Biosciences of California, Inc. · CIK 1299130 · Engraved from SEC EDGAR
0.2% from the close of Mar 12, 2015 to the close of Mar 13, 2015, the first after the release.
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Dec 31, 2014 · filed Mar 12, 2015 · 71 d after period end